Abortion Pill Reversal

Pro-life OB-GYNs launch initiative to increase abortion pill reversal providers

OB/GYN, newborn

The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) has launched a new initiative to increase the number of medical professionals who provide Abortion Pill Reversal (APR) treatment, which consists of administering the hormone progesterone to counteract the effects of mifepristone (the abortion pill), a progesterone blocker. To that end, the organization has launched a new page on its website and produced a new video, both of which answer common questions about APR from a medical provider’s perspective.

The webpage, entitled, “Give Your Patients a Second Chance at Life,” includes links to join the Abortion Pill Rescue Network, which connects women seeking APR to doctors who provide it via a 24/7 helpline staffed by trained nurses. It also contains a 12-question FAQ designed to address the most common questions posed by potential APR providers, including, “Should the Abortion Pill Reversal regimen not work, can I be held liable?” and “Will I be trained on how to administer the Abortion Pill Reversal regimen?” 

The video, which is also embedded on the page, is just over 22 minutes long and is designed to be a comprehensive information source regarding APR and what is involved in being a provider. It addresses and debunks the 11 most common myths regarding APR: it explains that the action of mifepristone is reversible through the process of reversible competitive inhibition, likening it to the action of leucovorin relative to methotrexate. It also uses Dr. Mary Davenport’s 2017 systematic review of related literature to demonstrate that fetal survival rates improve drastically when progesterone is administered following exposure to mifepristone, compared to zero intervention. It goes on to demonstrate that the Creinin study, which is often cited by APR opponents to support claims that APR is unsafe, actually proves that APR is effective — and that mifepristone is unsafe. 

READ: OBGYN: Pro-abortion orgs want to ‘make the discussion on Abortion Pill Reversal go away’

The video addresses concerns regarding the alleged “experimental” nature of APR, showing that progesterone has been used safely during early pregnancy for over 50 years; it also addresses the American College of Obstetricians and Gynecologists’ (ACOG) refusal to endorse APR by noting ACOG’s commitment to the abortion industry’s agenda. 

The video also answers potential concerns about the effect becoming an APR provider may have upon individual practices. It allays fears regarding a potential increase in medicolegal risk, explaining that the same informed consent protocols that protect doctors for other procedures apply to providing APR. It also explains that the services provided to members of the APR Network streamline the entire process for providers.

This resource is especially apt at this time, when pro-APR voices are being censored, making it more difficult for women to find this life-saving treatment. In September, for example, Google yanked Live Action’s ads for the Abortion Pill Reversal Network, citing their “unreliable claims” policy. However, they continue to allow unproven and outright phony “medical” products such as magnet-based arthritis treatments and cupping therapy products to be advertised while disallowing ads for a treatment that has been repeatedly proven effective.

With the radical increase in the proportion of chemical abortions relative to the total number of abortions — 43% as of 2020 — and with the relaxing of regulations governing the dispensing and distribution of the abortion pill, the demand for APR is very likely to increase, as well.

“Like” Live Action News on Facebook for more pro-life news and commentary!

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Corrections or Questions

For corrections, or questions, please contact the editor at [email protected]

GUEST ARTICLES: To submit a guest article to Live Action News, email [email protected] with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Thank you for your interest in Live Action News!



To Top